![](https://investorshub.advfn.com/uicon/522439.png?cb=1553675047)
Tuesday, February 23, 2016 10:07:58 AM
Today, it's listed at $5. So now I'm not sure if I had something in my eye and didn't see it right, or that someone called them out on it.
I think it's the right move to stock Bedrocan strains and Bedrocan prices because folks have a synergistic impression of the two companies.
The only justified price difference I can anticipate going forward is between taxes charged on RecMj and MedMJ. If Bedrocan takes the helm fully on MedMJ and Tweed for RecMJ, there is where I can see a reasonable price difference.
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM